NYSEMKT: ARMP
Armata Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

Analyst price target for ARMP

Based on 1 analyst offering 12 month price targets for Armata Pharmaceuticals Inc

Min Forecast
$9.00+246.15%
Avg Forecast
$9.00+246.15%
Max Forecast
$9.00+246.15%

Should I buy or sell ARMP stock?

Based on 1 analyst offering ratings for Armata Pharmaceuticals Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ARMP stock forecasts and price targets.

ARMP stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-05-19

1 of 1

ARMP vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ARMP$2.68$9.00+235.82%Buy
XBIT$3.20N/AN/A
SRZN$11.49$32.00+178.50%Buy
ANIX$3.06$9.00+194.12%Strong Buy
DOMH$6.48N/AN/A

Armata Pharmaceuticals Stock Forecast FAQ

Is Armata Pharmaceuticals Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NYSEMKT: ARMP) stock is to Buy ARMP stock.

Out of 1 analyst, 0 (0%) are recommending ARMP as a Strong Buy, 1 (100%) are recommending ARMP as a Buy, 0 (0%) are recommending ARMP as a Hold, 0 (0%) are recommending ARMP as a Sell, and 0 (0%) are recommending ARMP as a Strong Sell.

If you're new to stock investing, here's how to buy Armata Pharmaceuticals stock.

What is ARMP's Price Target?

According to 1 Wall Street analyst that have issued a 1 year ARMP price target, the average ARMP price target is $9.00, with the highest ARMP stock price forecast at $9.00 and the lowest ARMP stock price forecast at $9.00.

The Wall Street analyst predicted that Armata Pharmaceuticals's share price could reach $9.00 by May 19, 2026. The average Armata Pharmaceuticals stock price prediction forecasts a potential upside of 235.82% from the current ARMP share price of $2.68.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.